---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-102911"
form_type: "8-K"
ticker: "VERA"
cik: "0001831828"
company_name: "Vera Therapeutics, Inc."
filed_at: "2022-04-12T23:59:59+00:00"
generated_at: "2026-06-26T08:02:06.032581+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Vera Therapeutics names Michael Morrissey Ph.D. as Board Chair; von Emster resigns

## Summary
- Kurt von Emster resigns as director and Chair effective at 2022 annual meeting; no dispute.
- Michael Morrissey appointed to Board, becomes Chair, Class II director, term through 2023 annual meeting.
- Morrissey receives option grant of 40,000 shares (vs. standard 19,850) vesting over 3 years.
- Cash retainers: $65k as Chair, $7.5k on Audit Committee, $4k on Nominating Committee, pro-rated for 2022.
- Morrissey also appointed to Audit and Nominating Committees, effective annual meeting date.

## SEC filing metadata
- accession: 0001193125-22-102911
- form_type: 8-K
- ticker: VERA
- cik: 0001831828
- company_name: Vera Therapeutics, Inc.
- filed_at: 2022-04-12T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831828/000119312522102911/0001193125-22-102911-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831828/000119312522102911/d323101d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-102911
- JSON: https://secwatch.observer/filing/0001193125-22-102911.json
- Plain text: https://secwatch.observer/filing/0001193125-22-102911.txt

## Key facts
- Executive change
  Kurt von Emster resigned as Director and Chair at Vera Therapeutics, Inc..
  - Action: resigned
  - Role: Director and Chair
  source text: Kurt von Emster notified the board of directors (the “Board”) of Vera Therapeutics, Inc. (the “Company”) of his resignation as a director of the Company and as Chair of the Board, effective on the date of the Company’s 2022 Annual Meeting of Stockholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1831828/000119312522102911/0001193125-22-102911-index.htm
- Executive change
  Michael M. Morrissey, Ph.D. was appointed as Chair of the Board and Director at Vera Therapeutics, Inc..
  - Action: appointed
  - Role: Chair of the Board and Director
  source text: the Board appointed Michael M. Morrissey, Ph.D., to the Board, to fill the vacancy resulting from Mr. von Emster’s resignation, and to serve as Chair of the Board, effective on the Annual Meeting Date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1831828/000119312522102911/0001193125-22-102911-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.